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Vascular health late after Kawasaki disease: 
implications for accelerated atherosclerosis
Yiu-Fai Cheung, MD
Division of Paediatric Cardiology, Department of Paediatrics and Adolescent Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China
Kawasaki disease (KD), an acute vasculitis that primarily affects young children, is the most common 
acquired paediatric cardiovascular disease in developed countries.  While sequelae of arterial 
inflammation in the acute phase of KD are well documented, its late effects on vascular health are 
increasingly unveiled. Late vascular dysfunction is characterized by structural alterations and functional 
impairment in term of arterial stiffening and endothelial dysfunction and shown to involve both 
coronary and systemic arteries. Further evidence suggests that continuous low grade inflammation 
and ongoing active remodeling of coronary arterial lesions occur late after acute illness and may play a 
role in structural and functional alterations of the arteries. Potential importance of genetic modulation 
on vascular health late after KD is implicated by associations between mannose binding lectin and 
inflammatory gene polymorphisms with severity of peripheral arterial stiffening and carotid intima-
media thickening. The changes in cholesterol and lipoproteins levels late after KD further appear similar 
to those proposed to be atherogenic. While data on adverse vascular health are less controversial in 
patients with persistent or regressed coronary arterial aneurysms, data appear conflicting in individuals 
with no coronary arterial involvements or only transient coronary ectasia.  Notwithstanding, concerns 
have been raised with regard to predisposition of KD in childhood to accelerated atherosclerosis in 
adulthood. Until further evidence-based data are available, however, it remains important to assess 
and monitor cardiovascular risk factors and to promote cardiovascular health in children with a history 
of KD in the long term.
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Kawasaki disease (KD) is the most common acquired cardiovascular disease in 
children in developed countries1). This acute vasculitis, which affects primarily infants 
and young children, can have multiorgan involvements2). While systemic involvement 
is generally self-limiting, cardiovascular complications can be life-threatening3). Acute 
inflammatory damage to coronary and systemic arteries in the early phase of the illness 
has been well described4). A recent animal study using a KD mouse model suggested an 
important pathophysiologic link between coronary arteritis and subsequent acceleration 
of atherosclerosis, implicating that KD in childhood may potentially predispose to early 
atherosclerosis in adulthood5). Studies in adults with acute coronary syndrome also 
provided evidence of persistent risk of thrombosis in regressed coronary aneurysms6). 
Indeed, long-term structural alteration and functional disturbance of coronary and 
systemic arteries are increasingly recognized in adolescents and young adults with a 
history of KD. The focus of this review is on vascular health and cardiovascular risk profile 
late after KD, which may have implications on accelerated atherosclerosis in adulthood.
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Late coronary arterial abnormalities
1. Structural alteration
Structural alteration of coronary arterial wall after KD has 
been demonstrated using intravascular ultrasound. Sugimura et 
al.7) reported in KD patients examined at about 9 years after the 
acute illness intimal thickening and calcification at sites of the 
coronary aneurysms, and thickened but smooth intima at sites of 
regressed coronary aneurysms. Importantly, intimal thickening 
has been noted even in angiographically normal coronary arterial 
segments near to the site of persistent or regressed aneurysm. 
Similarly, Suzuki et al.8) have described thickened intima-media 
complex at sites of persistent and regressed aneurysms and in 
angiographically normal coronary arterial segments. Using 
virtual histologic-intravascular ultrasound, Mitani et al.9) found 
heterogeneous plaque areas with varying composition of fibrosis, 
fibrofatty, necrotic core, and dense calcium areas and provided 
insights into the potential role of atherogenesis in the evolution 
of coronary arterial lesions late after KD. In a pathological study 
of patients with history of KD who died after 15 years of age10), 
new intima thickening that superimposes on pre-existing intima 
thickening has been observed in coronary arteries with no 
previous formation of aneurysms.
While regression of coronary aneurysms is well described 
in KD3), new or expanding aneurysms have also been reported 
late after the acute illness11-14). The timing of detection of new 
aneurysms after KD ranges from 2 to 19 years after the 
acute phase14). The development of new aneurysms has been 
hypothesized to be related to abnormal arterial structures with 
superimposed haemodynamic disturbance in the presence of 
stenotic lesions. While clinical events associated with expanding 
aneurysms appear uncommon14), expanding aneurysms may be 
at risk of rupture11) and thrombosis.
Quantification of coronary arterial calcification has been 
used to assess the risk of developing coronary heart disease in 
asymptomatic adults with atherosclerosis15). During long-term 
follow-up of patients with KD, coronary arterial calcifications have 
been detected using electron beam computed tomography16-18). 
In a prospective, cohort study of 18 patients with KD at >1 year 
from the acute disease onset, coronary calcification was found in 
four of five patients with late echocardiographic abnormalities, 
but not in the 13 patients with no or resolved coronary arterial 
involvement17). Sudden death occurred in one patient who had 
the highest calcium score. The role of electron beam computed 
tomography-detected coronary arterial calcifications in the risk 
stratification of patients with KD warrants further assessments.
2. Coronary arterial stiffening
Endothelium-independent coronary dilation in patients with 
KD has been assessed by intracoronary infusion of agents that 
directly relax arterial smooth muscle. Sugimura et al.19) and 
Iemura et al.20) reported impairment of coronary vasodilatory 
response to intracoronary injection of isosorbide dinitrate at 
sites of persistent and regressed aneurysms. Similarly, impaired 
coronary vasoreactivity to intracoronary nitroglycerin at sites 
of regressed aneurysms has been shown8). In the latter study, 
decreased nitroglycerin reactivity has also been observed in 
segments without evidence of aneurysmal dilation. These 
data suggest that stiffening of the coronary artery occurs after 
KD, which may be related to smooth muscle dysfunction and 
pathological changes secondary to coronary arteritis.
3. Coronary endothelial dysfunction
In normal coronary arteries, local infusion of acetylcholine 
induces the release of nitric oxide from an intact endothelium to 
cause vasodilation and forms the basis of endothelial functional 
assessment21). On the other hand, paradoxical constriction 
of atherosclerotic coronary arteries may result from direct 
muscarinic action of acetylcholine on vascular smooth muscle. In 
patients with KD studied late after the acute illness, acetylcholine-
induced constriction of coronary arteries with persistent and 
regressed aneurysms has been found20,22,23).
Cold pressor test performed in conjunction with positron 
emission tomography can also be used to assess coronary 
endothelial function. In coronary arteries with normally func-
tioning endothelium, β-adrenergic activation due to cold stress 
increases coronary flow and induces vasodilation secondary to 
shear stress-induced release of nitric oxide from endothelial cells. 
On the other hand, the significantly lower myocardial blood flow 
found in patients with regressed aneurysms late after KD suggests 
coronary endothelial dysfunction24).
Although the exact mechanism of coronary endothelial 
dysfunction years after the acute illness remains to be elucidated, 
ongoing active vascular remodeling and chronic inflammatory 
processes as discussed below may be possible explanations. 
Existing data suggest endothelial dysfunction at sites of 
persistent and regressed aneurysms, but it remains controversial 
whether angiographically normal coronary arteries are similarly 
involved22,23).
4. Reduced myocardial flow reserve
Myocardial flow reserve as assessed by positron emission 
tomography24) and induction of hyperaemia by dipyridamole25) 
or adenosine triphosphate26) has been examined in patients 
with KD. In patients with regressed coronary aneurysms26) and 
even in those without documented coronary arterial lesions24,25), 
myocardial flow reserve has been shown to be reduced. The 
global rather than regional blood flow abnormalities suggest 
diffuse reduction of dilation capacity of the microcirculation. 
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Indeed, these findings agree with the diffuse nature of the 
vasculitic process as demonstrated by pathological27) and 
intravascular ultrasonography8) examinations. Although the 
clinical implications of these findings during childhood are 
unclear, reduced myocardial flow reserve is undoubtedly of 
significance in the event of superimposed coronary artery disease 
during adulthood. Using three-dimensional speckle tracking 
echocardiography, Yu et al.28) recently showed impairment of 
left ventricular strain in patients with and even in those without 
coronary aneurysms after the acute illness.
Late systemic arterial abnormalities
1. Increased carotid intima-media thickness
Carotid intima-media thickness has been regarded as a 
surrogate marker of atherosclerosis in adults29). In children with 
coronary aneurysms complicating KD, Noto et al.30) reported 
carotid intima-media thickening. Some small scale and nonage 
matched studies31,32), however, reported no differences in carotid 
intima-media thickness between patients and controls and 
among patients with varying involvement of coronary arteries. 
Subsequent studies that included age-matched controls or age-
adjusted standard deviation scores of intima-media thickness 
revealed carotid intima-media thickening not only in patients 
with coronary aneurysms, but also in those without coronary 
artery lesions33,34). A recent study of North American children and 
young adults, however, showed normal vascular health indices 
including carotid intima-media thickness in KD patients whose 
maximum coronary arterial dimensions had always been normal 
or only mildly ecstatic35). However, the mean left carotid intima 
media thickness tended to differ across different KD subgroups, 
being highest in patients with giant coronary arterial aneurysms. 
Whether the conflicting data are related to differences in ethnic 
backgrounds of study cohorts require further clarifications.
There have been discussions on whether thickening of the 
intima-media complex represents early atherosclerosis changes 
or a distinct KD vasculopathy related to luminal myofibroblastic 
proliferation36). The recent finding of a higher grey scale median 
of the carotid intima-media complex in patients with KD suggests 
that sclerotic vascular remodeling after KD may be distinct from 
the atherosclerotic remodeling, which has a lower grey scale 
median often observed in familial hypercholesterolaemia37).
2. Systemic arterial endothelial dysfunction
High-resolution ultrasound assessment of reactive hyperaemia 
of the brachial artery in response to sphygmomanometer cuff 
occlusion has been used to assess systemic arterial endothelial 
function based similarly on the principle of endothelium-de-
pendent release of nitric oxide in response to shear stress38). Using 
this technique, Dhillon et al.39) demonstrated significant reduction 
of brachial arterial flow-mediated dilation in KD patients, even in 
those without detectable coronary artery involvement, at a median 
of 11 years after the acute disease. In adults with a history of KD, 
flow-mediated dilation has similarly been found to be impaired40). 
Other investigators have, however, reported endothelial dys-
function only in patients with persistent coronary artery lesions31), 
being worse in those with coronary arterial aneurysms32). Others 
have, on the other hand, reported on normal brachial arterial flow-
mediated dilation in patients with KD41,42). The conflicting data in 
the literature and their possible reconciliation is discussed later in 
this review. Nonetheless, given the pathological processes during 
acute illness of endothelial necrosis and leukocyte infiltration of 
medium-sized arteries43,44), the late functional abnormalities of the 
brachial artery endothelium may be a long-term consequence of 
diffuse systematic inflammation.
3. Systemic arterial stiffening
Increased cross-sectional stiffness of carotid artery has been 
found in patients with KD with and without coronary aneurysms 
late after the acute illness30,33,45). The magnitude of carotid 
arterial stiffening was further shown to be related to serum high-
sensitivity C-reactive protein concentrations45) and carotid intima-
media thickness33) but not alternations in lipid profile30). Increased 
regional stiffness of the aorta and brachioradial and brachial-
ankle arterial segments, as evidenced by increased pulse wave 
velocity, has further been shown in patients with KD46-49). 
Arterial stiffness is directly related to characteristic impedance 
of the arterial bed, the pulsatile component of the afterload pre-
sented to the left ventricle. Indeed, invasive studies have shown 
significantly increased characteristic impedance and reduced total 
peripheral arterial compliance in patients with KD50), suggesting 
that both central and peripheral arterial wall stiffness is increased 
after KD. Importantly, this abnormal profile was found regardless 
of persistence of coronary arterial lesions. Structural alteration 
and endothelial dysfunction probably contribute to stiffening of 
the arterial tree in patients with KD late after the acute illness. 
Reparative process in the convalescent and chronic phase of 
the illness is characterized by intimal thickening, fibrous scar 
formation, and smooth muscle proliferation51-55), which may lead 
to an increase in vascular wall stiffness. Endothelial dysfunction 
may act by increasing vasomotor tone56,57). Stiffening of the 
arterial wall may increase intraluminal stress due to an increase 
in pulse pressure58) and predispose to vascular damage and 
atherosclerosis. The possibility of establishing a feedback loop in 
patients with KD has been hypothesized33). Indeed, carotid intima 
media thickness in KD patients has been shown to correlate 
with carotid arterial stiffness, after adjustment for potential 
confounding influence of age, sex, systemic blood pressure, and 
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serum cholesterol levels33).
4. Genotype and arterial sequelae
An association between mannose binding lectin gene mutation 
and coronary arterial complications has been reported in infants 
with KD59). Studies have furthermore shown modulating effects of 
mannose binding lectin genotypes on peripheral conduit arterial 
stiffness late after KD60). Patients with intermediate- or low-level 
mannose binding lectin expression genotypes were found to 
have stiffer peripheral conduit arteries than those with high-level 
expression genotypes. The mechanism of the modulating effects 
of mannose binding lectin genotypes remains speculative. Given 
that mannose binding protein binds to mannose and N-acetyl 
glucosamine residues on the surface of many microbial antigens 
and plays a role in complement activation and opsonization 
of microorganisms, a low serum mannose binding lectin level 
may be associated with delayed clearance of the triggering 
infectious agent, hence resulting in more significant acute arterial 
inflammation and late dysfunction. Indeed, inflammatory gene 
polymorphisms have been shown to influence vascular health 
of patients with KD late after the acute illness61). Specifically, 
C-reactive protein +1444 C>T and tumour necrosis factor-α-308 
G>A polymorphisms are shown to be associated with increased 
carotid arterial stiffness and intima media thickness in the long-
term.
Chronic low-grade inflammation
While widespread inflammatory damage of the coronary 
and other medium-sized muscular arteries occurs during the 
acute phase of KD, there is increasing evidence that vasculitis 
may continue in a low-grade fashion in the long-term62-64). In 
fatal cases of KD with despite apparent resolution of vascular 
inflammation and the absence of early detectable coronary 
artery abnormalities, the histological findings of infiltration 
of lymphocytes and plasma cells in the arterial wall suggest 
smoldering vasculitis62,63). Persistence of low-grade chronic 
inflammation is further evidenced by increased serum high-
sensitivity-C-reactive protein concentrations in children and 
adolescents with a history of KD complicated by coronary 
aneurysm formation, whether persistent or regressed45,65). The 
recent demonstration of persistent inflammation in vivo in a 40- 
year-old man with giant coronary aneurysm by positron emission 
tomography supports the concept of continuous smouldering 
vasculitis66).
Inflammatory processes play a pivotal role in atherogenesis67). 
The inflammatory response to vascular injury involves recruit-
ment and activation of monocytes through activation of mono-
cyte chemoattractant protein-167), which exerts its action by 
interacting with the chemokine receptor CCR2 on the surface of 
monocytes68). Cheung et al.69) demonstrated significant induction 
of monocyte chemoattractant protein-1 and CCR2 expression 
in THP-1 macrophages in vitro by the serum of children with a 
history of KD. C-reactive protein has been shown to upregulate 
CCR-2 expression in human monocytes70). Persistent elevation 
of baseline CRP level after KD45,65) may therefore play a role in 
chronic stimulation of the MCP-1/CCR2 pathway. Indeed, the 
magnitude of gene induction was found to correlate with serum 
high sensitivity-C-reactive protein level69). In vitro studies have 
further confirmed increased expression of monocyte chemo-
attractant protein-1 in coronary aneurysmal tissue from patients 
undergoing coronary artery bypass grafting70,71). Taken together, 
these findings suggest that chronic low-grade inflammation 
is associated with and may perhaps predispose to long-term 
structural and functional changes of arteries in patients with KD.
There is further evidence of ongoing active remodeling of 
coronary artery lesions even late after KD. In patients who died at 
2 to 12 years after onset of KD, extensive expression of vascular 
growth factors including transforming growth factor β1, platelet-
derived growth factor A, and basic fibroblast growth factor was 
found within and surrounding smooth muscle cells at stenotic 
and recanalized sites72). Limited histological evidence suggests a 
similar increase in the expression of vascular growth factors even 
in clinically normal coronary arteries after KD73).
Dyslipidaemia
Lipid abnormalities, specifically decreased total cholesterol, 
high-density lipoprotein (HDL)-cholesterol, and apoA-I levels, 
have been found in the acute phase of KD74-77). Newburger et al.74) 
further reported persistently reduced HDL cholesterol levels even 
at 3 years after the initial illness. Cheung et al.46) further showed 
that at a mean of 7.1 years after the acute illness, patients with 
KD and coronary aneurysms had lower HDL cholesterol and 
apolipoprotein A-I levels and higher apolipoprotein B levels, 
while in patients without aneurysms, the apolipoprotein B 
levels are also higher than controls. As severity of vasculitis in 
the acute phase may be reflected by development of coronary 
complications78), the findings of this latter study suggest that 
the magnitude of acute inflammation may have important 
relationships with late lipid abnormalities.
The alterations in cholesterol and lipoprotein profiles late after 
KD are similar to those predisposed to atherogenesis. Endothelial 
dysfunction documented late after resolution of the acute illness39) 
may diminish lipoprotein lipase activity with reduced generation 
of HDL cholesterol74). Furthermore, inhibition of lipoprotein 
lipase may decrease apoA-I level by increasing its catabolism79). 
In adults with chronic inflammation due to rheumatoid arthritis, 
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increased LDL cholesterol levels have been reported80). Given 
the evidence of low-grade chronic inflammation late after the 
acute illness, changes in lipid profile may be a reflection of such 
process.
Controversies
Notwithstanding the identification of vascular risk factors 
late after KD, evidence to the contrary exists in the literature. A 
number of explanations to reconcile conflicting data, especially 
in individuals of no coronary arterial involvements, has been 
proposed81). The relatively small sample size of different studies, 
the variable means to assess arterial stiffness and endothelial 
function, coexistence of other cardiovascular risk factors, and 
possible ethnic differences may have accounted for the different 
findings and conclusions. 
While alteration of arterial structure and function in patients 
with persistent or regressed coronary artery aneurysms is less 
controversial, the major question of whether vascular health late 
after the acute illness in individuals with no or only transient 
coronary arterial involvement will be similar to that of healthy 
subjects remains unanswered. The cardiovascular outcomes 
of the early Japanese cohorts who reach middle and older age 
would hopefully shed light on the answers to this issue82). In the 
latest update based on follow-up until 2009, for patients with 
cardiac sequelae due to KD, the mortality rate was significantly 
higher than that of the general population. On the other hand, 
the mortality rates of both male and female patients who did not 
have cardiac sequelae did not show any increase. Nonetheless, 
only about 6% of the entire cohort has reached age 30 to date. 
Conclusions
Structural alteration and functional disturbance of coronary 
and systemic arteries, chronic low grade inflammation, and 
dyslipidaemia may exist in children and young adults with 
a history of KD late after the acute illness, in particular in 
those with persistent or even regressed coronary aneurysms. 
Notwithstanding the existence of conflicting data, concerns have 
been raised with regard to predisposition of KD in childhood to 
accelerated atherosclerosis in adulthood. Until further evidence-
based data are available, it remains important to assess and 
monitor cardiovascular risk factors and to promote cardiovascular 
health in children with a history of KD in the long term.
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